← FDA Drug Approvals (Drugs@FDA)
DROXIDOPA
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CHARTWELL RX · Approved 2022-05-05
Drug application
- FDA Application #
ANDA214217- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DROXIDOPA
- Generic name
- Droxidopa
- Active ingredients
- DROXIDOPA
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- CHARTWELL RX
- First approval
- 2022-05-05
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown